Back
Milestone Pharmaceuticals, Inc. Vs. Novartis AG Industry Stock Comparison
Sell
38
MIST
Milestone Pharmaceuticals, Inc.
Last Price:
$2.06
Seasonality Move:
-24.75%
Buy
76
NVSEF
Novartis AG
Last Price:
$141.60
Seasonality Move:
-2.68%
Sell
38
Milestone Pharmaceuticals, Inc. (MIST)
is a Sell
Is Milestone Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Milestone Pharmaceuticals, Inc. [MIST] share price is $2.02. The Score for MIST is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
MIST is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
76
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $138.00. The Score for NVSEF is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MIST Stock Price Chart
What is Milestone Pharmaceuticals, Inc.'s stock price today?
-
The Milestone Pharmaceuticals, Inc. share price today is $2.02The current trend is relatively stagnant and MIST is experiencing slight selling pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $138.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
MIST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 41.51 | Sell |
| Chaikin Money Flow: | -1131260 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.06 - 2.66) | Sell |
| Bollinger Bands (100): | (1.75 - 2.33) | Sell |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.86 | Buy |
| Relative Strength Index (14 RSI): | 62.35 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (126.72 - 136.66) | Buy |
| Bollinger Bands (100): | (122.54 - 132.72) | Buy |
MIST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.03 | Sell |
| 20-day SMA: | 2.29 | Sell |
| 50-day SMA: | 2.18 | Sell |
| 200-day SMA: | 1.75 | Buy |
| 8-day EMA: | 2.06 | Sell |
| 20-day EMA: | 2.18 | Sell |
| 50-day EMA: | 2.05 | Sell |
| 200-day EMA: | 1.04 | Buy |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 137.75 | Buy |
| 20-day SMA: | 132.52 | Buy |
| 50-day SMA: | 129.1 | Buy |
| 200-day SMA: | 120.44 | Buy |
| 8-day EMA: | 136.94 | Buy |
| 20-day EMA: | 133.89 | Buy |
| 50-day EMA: | 130.49 | Buy |
| 200-day EMA: | 121.97 | Buy |
Milestone Pharmaceuticals, Inc. Earnings Growth & MIST Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.31 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Milestone Pharmaceuticals, Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||